← All Bioxytran, INC filings

Bioxytran, INC S-1 registration statements

Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.

OQB
BIXT
Bioxytran, INC
S-1/A: Bioxytran Files Amendment to S-1 Registration Statement for Common Stock Offering
Bioxytran, Inc. files an amendment to its S-1 registration statement to include the opinion of legal counsel regarding the legality of issuing up to 18,000,000 shares of common stock.
OQB
BIXT
Bioxytran, INC
S-1/A: Bioxytran Files for Resale of 18 Million Shares Following Agreement with Triton Funds LP
Bioxytran is registering the resale of 18 million common shares by a selling stockholder, TRITON FUNDS LP, following a closing agreement for a maximum principal amount of $1.6 million.
OQB
BIXT
Bioxytran, INC
S-1: Bioxytran Files for Resale of 18 Million Common Shares Following Agreement with Triton Funds LP
Bioxytran, a clinical-stage pharmaceutical company, has filed a registration statement for the resale of 18 million shares of its common stock by a selling stockholder, Triton Funds LP.